{
    "nctId": "NCT04065321",
    "briefTitle": "Circulating Tumor Cell Detection in Patients With Luminal A Breast Cancer",
    "officialTitle": "Effect of Circulating Tumor Cell Detection in Patients With Luminal A Breast Cancer Without Lymph Node Metastasis Instead of Conventional Imaging Examination After Operation: a Non-Inferiority Randomized Controlled Clinical Trial",
    "overallStatus": "RECRUITING",
    "conditions": "Breast Neoplasms",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 500,
    "primaryOutcomeMeasure": "Disease-free survival",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* estrogen receptor (\u2265 10%), progesterone receptor (\u2265 10%) and epidermal growth factor receptor 2 negative;\n* proliferation index Ki-67 \\< 20%;\n* no lymph node metastasis;\n* systemic therapy (chemotherapy, radiotherapy and endocrine therapy) in accordance with the National Comprehensive Cancer Network guidelines;\n* provision of informed consent of patients and their families.\n\nExclusion Criteria:\n\n* Bilateral breast cancer;\n* inflammatory breast cancer;\n* pregnancy or lactation;\n* history of other cancers or chest radiotherapy.",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT"
}